1. Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom.
- Author
-
Torres-Huaco FD, Ponce-Soto LA, Martins-de-Souza D, and Marangoni S
- Subjects
- Amino Acid Sequence, Analysis of Variance, Animals, Chromatography, Gel, Chromatography, High Pressure Liquid, Chromatography, Reverse-Phase, Crotalid Venoms isolation & purification, Crotalid Venoms pharmacology, Fibrinogen metabolism, Hemorrhage chemically induced, Hemorrhage enzymology, Male, Metalloproteases isolation & purification, Metalloproteases pharmacology, Mice, Molecular Sequence Data, Sequence Alignment, Sequence Analysis, Protein, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Temperament, Bothrops metabolism, Crotalid Venoms chemistry, Metalloproteases chemistry
- Abstract
BmHF-1, from the venom of Bothrops marajoensis, was purified by Sephadex G-75 and HPLC-RP on micro-Bondapak C-18 column chromatography. It presented a molecular mass of 27162.36 Da determined by MALDI-TOF MS. BmHF-1 had a sequence of 238 residues of amino acids. The multiple alignment of its amino acid sequence and those of other snake venom metalloproteinases showed high structural similarity, mainly among P-I class. The enzyme initially cleaves the Aalpha-chain of fibrinogen, followed by the Bbeta-chain, and shows no effects on the gamma-chain. BmHF-1 had, caseinolytic and weakly hemorrhagic activities, which were inhibited by EDTA. In contrast, PMSF did not affect these activities. The caseinolytic activity of BmHF-1 had a pH optimum of 8.0 and was stable in solution up to 40 degrees C; activity was completely lost at > or = 70 degrees C. The proteolytic activity was also inhibited by sDa (opossum sera) and Da2-1, Da2-II, antihemorrhagic factors isolated from the opossum sera of Didelphis albiventris. BmHF-1 presents weak hemorrhagic activity, with a MHD of 41.14 microg and it induces dose-dependent edema. We could concluded that, despite its weak hemorrhagic activity, BmHF-1 contributes to local tissue damage by inducing edema, releasing pharmacologically active mediators from protein precursors due to its enzymatic action.
- Published
- 2010
- Full Text
- View/download PDF